Hemorrhagic diatheses in children. Gastrointestinal bleedings. Sakharova I. Ye., MD, PhD.

Slides:



Advertisements
Similar presentations
The Basics of Hemophilia
Advertisements

Coagulation: Review & Lab techniques
Hemorrhagic diseases. Lesions of the blood vessels Lesions of the blood vessels Abnormal platelets Abnormal platelets Abnormalities in the coagulation.
Bleeding disorders Doc. MUDr. L. Boudová, Ph.D.. Bleeding disorders I. Vessels - increased fragility II. Platelets - deficiency or dysfunction III.Coagulation.
BLEEDING DISORDERS AN OVERVIEW WITH EMPHASIS ON EMERGENCIES.
Initiation substances activate s by proteolysis a cascade of circulating precursor proteins which leads to the generation of thrombin which in turn converts.
Hemostatic System - general information Normal hemostatic system –vessel wall –circulating blood platelets –blood coagulation and fibrynolysis Platelets.
Disorder of hemostasis. Haemophylia. Trombocytopenias
Haemostasis Tiffany Shaw MBChB II Haemostasis Pathway Injury Collagen exposure Tissue Factor Platelet adhesion Coagulation Cascade Release reaction.
Anatomy and Physiology 3/15 and 3/16
Gatmaitan, Raymond Vincent Golpeo, Kirsten C.
MLAB 1227: Coagulation Keri Brophy-Martinez
By: Bekim Ameti. Information On Hemophilia Hemophilia is the oldest known heredity bleeding disorder. Hemophilia has been known for thousands of years.
Dr MOHAMMED H SAIEMALDAHR FACULTY of Applied Medical Sciences
MISHA MAZHAR 2k10-NUST-BS-V&I-54.  Mutations in F8 or F9 genes.  Leads to lack of proteins made by these genes.  F8 responsible for making the blood.
Lecture NO- 12- Dr: Dalia Kamal Eldien.  Coagulation: Is the process by which blood changes from a liquid to a clot. Coagulation begins after an injury.
Blood disorders.
This lecture was conducted during the Nephrology Unit Grand Ground by a Sub-intern under Nephrology Division, Department of Medicine in King Saud University.
THROMBOCYTOPENIA - reduced platelet count -. First of all.. what are platelets? Platelets: tiny cells that circulate in the blood and whose function is.
HPI: A 4-year-old female. Referred to the hematology department. C/C:
Autoimmune Idiopathic Thrombocytopenic Purpura (ITP) Nicola Davis.
Hemophilia A By Marissa Miuccio.
HMIM BLOCK 224 PLATELET AND HEMOSTASIS Dr. Zahoor Lecture - 6.
Bleeding Disorders Dr. Farjah H.AlGahtani
Hemorrhagic diatheses in children
Sarah Moreno Ms.Brown Child dev. -6
Approach to Bleeding Disorders
Nephrology Diseases & Chemotherapy. Idiopathic Nephrotic Syndrome (NS) Caused by renal diseases that increase the permeability across the glomerular filtration.
RHEUMATIC HEART DISEASE D. HANA OMER. OBJECTIVES To know definition, symptoms, signs, diagnosis of Rheumatic fever. To know the treatment of Rheumatic.
The hemophilias A and B X-linked hereditary blood clotting disorders due to deficiency of factor VIII (hemophilia A) or factor IX (hemophilia B) Identical.
Bleeding Disorders JANUARY 19, 2012 Erin M. Kwolek.
Hemophilia  Definition: rare bleeding disorders due to inherited deficiencies in co-agulation factors  Types: 1. Haemophilia A (Classic) Factor VIII.
Morning Report August 4, 2009.
Clinical Presentation of DHF. Dengue should be considered in the differential diagnosis of febrile patients with a history of travel to the tropics in.
ASSOCIATE PROFESSOR IOLANDA BLIDARU MD, PhD.
Clinical Features.
Bleeding and Kristine Krafts, M.D. Thrombotic Disorders.
Hematology Blueprint PANCE Blueprint. Coagulation Disorders.
Idiopathic Thrombocytopenic Purpura Clinical Features.
Thrombotic Thrombocytopenic Purpura (TTP)
HEMOSTASIS When blood vessels are cut or damaged, the loss of blood from the system must be stopped before shock and possible death occur. This is accomplished.
The Basics of Hemophilia. Hemostatic System Blood vessels Platelets Plasma coagulation system Proteolytic or Fibrinolytic system.
1. Normal haemostasis Haemostasis is the process whereby haemorrhage following vascular injury is arrested. It depends on closely linked interaction.
Thrombocytopenia Chapter 31 Copyright © 2014 by Mosby, an imprint of Elsevier Inc.
Approach to the Bleeding Child. Evaluation  History Current Bleeding Medical Family  Physical exam  Selected laboratory investigations.
Henoch-Scholein Purpura. Introduction Systemic vasculitis with a prominent cutaneous component. Systemic vasculitis with a prominent cutaneous component.
Abnormal bleeding in children J Kiwanuka. GENERAL INTRODUCTION.
Bleeding disorders. Sudden onset of palpable purpura ( localized, raised hemorrhages in the skin ) in association with rash and fever.
Clinical presentation of a child with abnormal bleeding Dr Barnabas R Atwiine.
Platelets. Fig Hemostasis the process by which the bleeding is stopped from broken vessels. steps involved: Vascular spasm. Platelets plug formation.
Obada Al-Eisa Saud Bashtawy Emad Mansour.  It is an acquired condition characterized by massive activation of the coagulation system.  It is always.
Congenital bleeding disorders
Bleeding disorders due to vascular & platelets abnormalities
Bleeding disorders Deficiency of any of the clotting factors leads to excessive bleeding Most common and important bleeding disorders are due Vitamin K.
Multiple choice questions
Blood Disorders.
Hemophilia 2009.
Hemophilia Brandon Vilorio.
HEMOPHELIA.
Coagulation cascade:.
Haematology.
Henoch–Schönlein Purpura (HEN-awk SHURN-line PUR-pu-ruh)
Diagnosis Approach of Bleeding in Children ________________________________ Ketut Ariawati Hematologi Onkologi RSUP Sanglah Denpasar.
Dr-Majid Qanavat Ped. Hematologist oncologist Isfahan university -1396
Congenital bleeding disorders
Henoch-Schönlein Purpura. WHAT IS Henoch-Schönlein Purpura  Also called anaphylactoid purpura  Henoch-Schönlein purpura (HSP) is the most common form.
Bleeding and Thrombotic Disorders Kristine Krafts, M.D.
Hemophilia By: Renee Marie Alta.
Immune thrombocytopenic purpura (ITP)
The child with hematological dysfunction
Presentation transcript:

Hemorrhagic diatheses in children. Gastrointestinal bleedings. Sakharova I. Ye., MD, PhD

2 The stopping of a bleeding is carried out due to three parts of a hemostasis: 1.Vascular integrity. 2.Qualitative and quantitative characteristics of platelets. 3.Presence of coagulation factors in blood.

3 According to this all hemorrhagic diatheses are divided into 3 groups: 1. Vasopathies 2. Thrombopathias 3. Coagulopathies

4 Schönlein-Henoch purpura (synonims - anaphylactoid purpura, allergic angiitis, small-vessel vasculitis, hemorrhagic vasculitis, Henoch-Schönlein disease) is one of the collagen vascular diseases in which basis lays immune complex mechanism of small vessels wall damaging with skin, joints, intestine and kidneys affection.

5 Clinical features. Papular- macular hemorrhagic purpuric lesions. Typical places of rush localization: extensor surfaces of legs, on the feet, over the joints, on the buttocks; occasionally, they may occur on the hands, extensor surfaces of arms, elbows, and face, but very rarely on the trunk.

6

7

8

9

10 Clinical features of the Sch ö nlein- Henoch purpura.  joints involvement  acute abdominal pain, vomiting, melena  renal involvements (microscopic hematuria, with or without proteinuria)  scrotal involvement (epydidimitis, orchitis, and scrotal bleeding)

11

12 Idiopathic thrombocytopenic purpura (ITP, primary immune thrombocytopenic purpura, autoimmune thrombocytopenic purpura) describes an autoimmune disorder in which the number of circulating platelets is less than 150 G/l.

13 Clinical features. The onset of the disease is usually sudden. The symptoms of intoxication and fever usually are absent. Skin purpura, which arises either spontaneously or secondary to trauma. The type of rush is petechial- bruise. The second frequent clinical sign are bleedings. In the beginning of the disease can be nose bleeding (epistaxis), bleeding from gums, mucous membranes, gastrointestinal tract, kidneys and metrorrhagias (uterinal bleedings). Hemorrhage into the central nervous system, the most serious complication of thrombocytopenia.

14

15

16 Hemophilia A and B are inherited bleeding disorders caused by deficiencies of clotting factor VIII (F VIII - antigemophilic globulin (AHG)) and factor IX (F IX - plasma thromboplastin component (PTC) or Christmas factor) correspondingly.

17 Mechanism of hemophilia inheritance XyXy xx xy XxXx XxXx XyXy xxXxXx XyXy XXxXx xy XyXy

18 Prophylactic treatment The aim of this treatment is to maintain 5 % factor activity in patient’s blood. Start from the age of 1-2 years. Use monoclonal-antibody purified F VІІІ, F ІХ and recombinant F VІІІ, F ІХ 3 times in week in hemophilia A and 2 times in week in hemophilia B IU/kg.

19 Treatment of acute bleeding episodes Hemophilia A –Fresh frozen plasma (100 ml=80IU АHG) Dose is ml/kg IV during min, repeat after 8-12 hours. –Cryoprecipitate – Monoclonal-antibody purified F VІІІ and recombinant F VІІІ Hemophilia B – Fresh frozen plasma – Monoclonal-antibody purified F IX and recombinant F IX

20 During severe or dangerous (e.g. CNS, retroperitoneal) bleeds need to obtain % factor activity for 7-10 days. For less critical situations (e.g. dental extractions, haematuria, soft tissue bleeds), 20-50% factor activity for 2-7 days are generally sufficient. For uncomplicated haemarthroses or superficial muscle or soft tissue bleeds, 20-30% for 1-2 days.

21 Laboratory differential diagnostics of hemorrhagic diatheses Count of platelets Time of bleeding Coagula tion time Clot retrac- tion Coagulo gram Hem. vaskul. ITP Trombopathia Hemophilia nnnnnn nnnnnnnn nnnnnn nnnnnn nnnnnn

22

23

24

25

26

27

28

29

30

31

32

33

34

35

36

37

38

39

40

41

42 Success is not final, failure is not fatal. It is the courage to continue that counts. Winston Churchill

43